Vimarsana
Biggest News Aggregation in the World

Page 9 - Forward Looking Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Forward Looking Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Forward Looking Statement Today - Breaking & Trending Today

Centerspace (NYSE:CSR) Q4 2023 Earnings Call Transcript - Vimarsana News

Centerspace (NYSE:CSR) Q4 2023 Earnings Call Transcript

Centerspace (NYSE:CSR) Q4 2023 Earnings Call Transcript February 21, 2024 Centerspace isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, everyone, and welcome to the Centerspace Q4 2023 Earnings Call. My name is Harry, and I’ll be coordinating your […]

Source: yahoo.com
GFL Environmental Inc. (NYSE:GFL) Q4 2023 Earnings Call Transcript - Vimarsana News

GFL Environmental Inc. (NYSE:GFL) Q4 2023 Earnings Call Transcript

GFL Environmental Inc. (NYSE:GFL) Q4 2023 Earnings Call Transcript February 21, 2024 GFL Environmental Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Drew and I’ll be your conference operator today. At this time, I […]

Source: yahoo.com
Avis Budget Group Announces Intention to Offer EUR400 Million of Senior Notes - Vimarsana News

Avis Budget Group Announces Intention to Offer EUR400 Million of Senior Notes

PARSIPPANY, N.J., - Avis Budget Group, Inc. announced today that its wholly-owned subsidiary, Avis Budget Finance plc , intends, subject to market and other customary conditions, to offer EUR400...

CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA - Vimarsana News

CASI PHARMACEUTICALS ANNOUNCES FIRST DOSING OF FOLOTYN® IN CHINA

CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products, proudly announced the administration of the first dose of FOLOTYN® (Pralatrexate Injection) to a patient in China. This remarks a pivotal step in CASI's commitment to addressing critical medical needs in peripheral T-cell lymphoma in China market.

Source: yahoo.com
SunPower Corporation (NASDAQ:SPWR) Q4 2023 Earnings Call Transcript - Vimarsana News

SunPower Corporation (NASDAQ:SPWR) Q4 2023 Earnings Call Transcript

SunPower Corporation (NASDAQ:SPWR) Q4 2023 Earnings Call Transcript February 15, 2024 SunPower Corporation misses on earnings expectations. Reported EPS is $-0.51 EPS, expectations were $-0.27. SPWR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, welcome to SunPower Corporation’s […]

Source: yahoo.com